Skip to main content
SpringerLink
Log in

Critical Care Management of Subarachnoid Hemorrhage

  • Chapter
  • First Online:
Textbook of Neuroanesthesia and Neurocritical Care

Abstract

Subarachnoid hemorrhage (SAH) caused by rupture of a cerebral aneurysm puts patients at risk for a variety of early and delayed complications that can worsen outcome. Timely diagnosis of SAH by CT or lumbar puncture is essential. After initial stabilization, patients with SAH should be transferred to high-volume centers where vascular neurosurgeons or interventional neuroradiologists secure the aneurysm. Patients should be monitored and treated in dedicated neurocritical care units with multidisciplinary teams that have experience in prevention and treatment of complications including hyponatremia, hydrocephalus, vasospasm, and delayed cerebral ischemia. This chapter summarizes current evidence and recommendations for the critical care management of patients with SAH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519–36.

    Article  Google Scholar 

  2. Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Emond M, Symington C, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ. 2011;343:d4277.

    Article  Google Scholar 

  3. Bakr A, Silva D, Cramb R, Flint G, Foroughi M. Outcomes of CSF spectrophotometry in cases of suspected subarachnoid haemorrhage with negative CT: two years retrospective review in a Birmingham hospital. Br J Neurosurg. 2017;31(2):223–6.

    Article  CAS  Google Scholar 

  4. Tang C, Zhang TS, Zhou LF. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis. PLoS One. 2014;9(6):e99536.

    Article  Google Scholar 

  5. Bardach NS, Zhao S, Gress DR, Lawton MT, Johnston SC. Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke. 2002;33(7):1851–6.

    Article  Google Scholar 

  6. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32(5):1176–80.

    Article  CAS  Google Scholar 

  7. Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RS. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385(9969):691–7.

    Article  Google Scholar 

  8. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360(9342):1267–74.

    Article  Google Scholar 

  9. Boogaarts HD, van Lieshout JH, van Amerongen MJ, de Vries J, Verbeek AL, Grotenhuis JA, et al. Aneurysm diameter as a risk factor for pretreatment rebleeding: a meta-analysis. J Neurosurg. 2015;122(4):921–8.

    Article  Google Scholar 

  10. Cagnazzo F, Gambacciani C, Morganti R, Perrini P. Aneurysm rebleeding after placement of external ventricular drainage: a systematic review and meta-analysis. Acta Neurochir. 2017;159(4):695–704.

    Article  Google Scholar 

  11. van Donkelaar CE, Bakker NA, Veeger NJ, Uyttenboogaart M, Metzemaekers JD, Luijckx GJ, et al. Predictive factors for rebleeding after aneurysmal subarachnoid Hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study. Stroke. 2015;46(8):2100–6.

    Article  Google Scholar 

  12. Starke RM, Connolly ES Jr, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Rebleeding after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):241–6.

    Article  CAS  Google Scholar 

  13. Guo LM, Zhou HY, Xu JW, Wang Y, Qiu YM, Jiang JY. Risk factors related to aneurysmal rebleeding. World Neurosurg. 2011;76(3–4):292–8. discussion 53–4.

    Article  Google Scholar 

  14. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97(4):771–8.

    Article  CAS  Google Scholar 

  15. Varelas P, Helms A, Sinson G, Spanaki M, Hacein-Bey L. Clipping or coiling of ruptured cerebral aneurysms and shunt-dependent hydrocephalus. Neurocrit Care. 2006;4(3):223–8.

    Article  Google Scholar 

  16. O’Kelly CJ, Kulkarni AV, Austin PC, Urbach D, Wallace MC. Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: incidence, predictors, and revision rates. J Neurosurg. 2009;111(5):1029–35.

    Article  Google Scholar 

  17. Hoh BL, Kleinhenz DT, Chi YY, Mocco J, Barker FG 2nd. Incidence of ventricular shunt placement for hydrocephalus with clipping versus coiling for ruptured and unruptured cerebral aneurysms in the Nationwide inpatient sample database: 2002 to 2007. World Neurosurg. 2011;76(6):548–54.

    Article  Google Scholar 

  18. Huttunen J, Kurki MI, von Und Zu Fraunberg M, Koivisto T, Ronkainen A, Rinne J, et al. Epilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study. Neurology. 2015;84(22):2229–37.

    Article  Google Scholar 

  19. Huttunen J, Lindgren A, Kurki MI, Huttunen T, Frosen J, Koivisto T, et al. Epilepsy-associated long-term mortality after aneurysmal subarachnoid hemorrhage. Neurology. 2017;89(3):263–8.

    Article  Google Scholar 

  20. Choudhari KA, Kaliaperumal C. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery. 2007;61(6):E1340. author reply E.

    Article  Google Scholar 

  21. Marigold R, Gunther A, Tiwari D, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage. Cochrane Database Syst Rev. 2013;(6):CD008710.

    Google Scholar 

  22. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36(3):583–7.

    Article  CAS  Google Scholar 

  23. Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010;12(2):165–72.

    Article  CAS  Google Scholar 

  24. Karamchandani RR, Fletcher JJ, Pandey AS, Rajajee V. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2014;21(9):1507–13.

    Article  CAS  Google Scholar 

  25. Dennis LJ, Claassen J, Hirsch LJ, Emerson RG, Connolly ES, Mayer SA. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1136–43. discussion 44.

    Article  Google Scholar 

  26. Claassen J, Perotte A, Albers D, Kleinberg S, Schmidt JM, Tu B, et al. Nonconvulsive seizures after subarachnoid hemorrhage: multimodal detection and outcomes. Ann Neurol. 2013;74(1):53–64.

    Article  Google Scholar 

  27. Claassen J, Albers D, Schmidt JM, De Marchis GM, Pugin D, Falo CM, et al. Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol. 2014;75(5):771–81.

    Article  CAS  Google Scholar 

  28. Moussouttas M, Lai EW, Dombrowski K, Huynh TT, Khoury J, Carmona G, et al. CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Neurocrit Care. 2011;14(3):401–6.

    Article  CAS  Google Scholar 

  29. Lee VH, Oh JK, Mulvagh SL, Wijdicks EF. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243–9.

    Article  Google Scholar 

  30. Malik AN, Gross BA, Rosalind Lai PM, Moses ZB, Du R. Neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2015;83(6):880–5.

    Article  Google Scholar 

  31. Ibrahim GM, Macdonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2012;43(8):2102–7.

    Article  Google Scholar 

  32. Ichinomiya T, Terao Y, Miura K, Higashijima U, Tanise T, Fukusaki M, et al. QTc interval and neurological outcomes in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):347–54.

    Article  Google Scholar 

  33. Muroi C, Keller M, Pangalu A, Fortunati M, Yonekawa Y, Keller E. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):188–92.

    Article  Google Scholar 

  34. Junttila E, Ala-Kokko T, Ohtonen P, Vaarala A, Karttunen A, Vuolteenaho O, et al. Neurogenic pulmonary edema in patients with nontraumatic intracerebral hemorrhage: predictors and association with outcome. Anesth Analg. 2013;116(4):855–61.

    Article  Google Scholar 

  35. Nastasovic T, Milakovic B, Marinkovic JE, Grujicic D, Stosic M. Could cardiac biomarkers predict neurogenic pulmonary edema in aneurysmal subarachnoid hemorrhage? Acta Neurochir. 2017;159(4):705–12.

    Article  Google Scholar 

  36. Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–5.

    Article  Google Scholar 

  37. Neidert MC, Maldaner N, Stienen MN, Roethlisberger M, Zumofen DW, D’Alonzo D, et al. The Barrow neurological institute grading scale as a predictor for delayed cerebral ischemia and outcome after aneurysmal subarachnoid Hemorrhage: data from a Nationwide patient registry (Swiss SOS). Neurosurgery. 2018;83(6):1286–93.

    Article  Google Scholar 

  38. Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31(6):1443–51.

    Article  CAS  Google Scholar 

  39. Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58.

    Article  CAS  Google Scholar 

  40. Dreier JP, Fabricius M, Ayata C, Sakowitz OW, William Shuttleworth C, Dohmen C, et al. Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: review and recommendations of the COSBID research group. J Cereb Blood Flow Metab. 2017;37(5):1595–625.

    Article  Google Scholar 

  41. Woitzik J, Dreier JP, Hecht N, Fiss I, Sandow N, Major S, et al. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012;32(2):203–12.

    Article  Google Scholar 

  42. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery. 2006;59(4):781–7. discussion 7–8.

    Article  Google Scholar 

  43. Suarez JI. Diagnosis and management of subarachnoid hemorrhage. Continuum (Minneap Minn). 2015;21(5 Neurocritical Care):1263–87.

    Google Scholar 

  44. Kumar G, Shahripour RB, Harrigan MR. Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurosurg. 2016;124(5):1257–64.

    Article  Google Scholar 

  45. Sanelli PC, Anumula N, Johnson CE, Comunale JP, Tsiouris AJ, Riina H, et al. Evaluating CT perfusion using outcome measures of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2013;34(2):292–8.

    Article  CAS  Google Scholar 

  46. Claassen J, Hirsch LJ, Kreiter KT, Du EY, Connolly ES, Emerson RG, et al. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol. 2004;115(12):2699–710.

    Article  Google Scholar 

  47. Rots ML, van Putten MJ, Hoedemaekers CW, Horn J. Continuous EEG monitoring for early detection of delayed cerebral ischemia in subarachnoid hemorrhage: a pilot study. Neurocrit Care. 2016;24(2):207–16.

    Article  CAS  Google Scholar 

  48. Eide PK, Sorteberg A, Bentsen G, Marthinsen PB, Stubhaug A, Sorteberg W. Pressure-derived versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in relation to early clinical state and 12-month outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2012;116(5):961–71.

    Article  Google Scholar 

  49. Johnson U, Engquist H, Howells T, Nilsson P, Ronne-Engstrom E, Lewen A, et al. Bedside Xenon-CT shows lower CBF in SAH patients with impaired CBF pressure autoregulation as defined by Pressure Reactivity Index (PRx). Neurocrit Care. 2016;25(1):47–55.

    Article  Google Scholar 

  50. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000277.

    Google Scholar 

  51. Liu GJ, Wang ZJ, Wang YF, Xu LL, Wang XL, Liu Y, et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol. 2012;68(2):131–9.

    Article  CAS  Google Scholar 

  52. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41(5):921–6.

    Article  CAS  Google Scholar 

  53. Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD, Collaborators S. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014;13(7):666–75.

    Article  CAS  Google Scholar 

  54. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618–25.

    Article  CAS  Google Scholar 

  55. Treggiari MM, Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):329–35.

    Article  Google Scholar 

  56. Kasuya H, Onda H, Yoneyama T, Sasaki T, Hori T. Bedside monitoring of circulating blood volume after subarachnoid hemorrhage. Stroke. 2003;34(4):956–60.

    Article  Google Scholar 

  57. Hoff RG, van Dijk GW, Algra A, Kalkman CJ, Rinkel GJ. Fluid balance and blood volume measurement after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;8(3):391–7.

    Article  Google Scholar 

  58. Hoff R, Rinkel G, Verweij B, Algra A, Kalkman C. Blood volume measurement to guide fluid therapy after aneurysmal subarachnoid hemorrhage: a prospective controlled study. Stroke. 2009;40(7):2575–7.

    Article  Google Scholar 

  59. Germans MR, de Witt Hamer PC, van Boven LJ, Zwinderman KA, Bouma GJ. Blood volume measurement with indocyanine green pulse spectrophotometry: dose and site of dye administration. Acta Neurochir. 2010;152(2):251–5. discussion 5.

    Article  Google Scholar 

  60. Gathier CS, van den Bergh WM, van der Jagt M, Verweij BH, Dankbaar JW, Muller MC, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2018;49(1):76–83.

    Article  Google Scholar 

  61. Kimball MM, Velat GJ, Hoh BL, Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care. 2011;15(2):336–41.

    Article  Google Scholar 

  62. Mapa B, Taylor BE, Appelboom G, Bruce EM, Claassen J, Connolly ES Jr. Impact of Hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg. 2016;85:305–14.

    Article  Google Scholar 

  63. Kao L, Al-Lawati Z, Vavao J, Steinberg GK, Katznelson L. Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary. 2009;12(4):347–51.

    Article  Google Scholar 

  64. Hannon MJ, Behan LA, O’Brien MM, Tormey W, Ball SG, Javadpour M, et al. Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. J Clin Endocrinol Metab. 2014;99(1):291–8.

    Article  CAS  Google Scholar 

  65. Peri A. Clinical review: the use of vaptans in clinical endocrinology. J Clin Endocrinol Metab. 2013;98(4):1321–32.

    Article  CAS  Google Scholar 

  66. Aylwin S, Burst V, Peri A, Runkle I, Thatcher N. ‘Dos and don’ts’ in the management of hyponatremia. Curr Med Res Opin. 2015;31(9):1755–61.

    Article  CAS  Google Scholar 

  67. Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Neurocrit Care. 2011;15(2):354–60.

    Article  Google Scholar 

  68. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med. 2008;36(7):2070–5.

    Article  Google Scholar 

  69. Kurtz P, Schmidt JM, Claassen J, Carrera E, Fernandez L, Helbok R, et al. Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit Care. 2010;13(1):10–6.

    Article  CAS  Google Scholar 

  70. Sampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care. 2010;12(1):4–9.

    Article  Google Scholar 

  71. Manoel AL, Turkel-Parrella D, Germans M, Kouzmina E, Almendra Pda S, Marotta T, et al. Safety of early pharmacological thromboprophylaxis after subarachnoid hemorrhage. Can J Neurol Sci. 2014;41(5):554–61.

    Article  Google Scholar 

  72. Zachariah J, Snyder KA, Graffeo CS, Khanal DR, Lanzino G, Wijdicks EF, et al. Risk of ventriculostomy-associated hemorrhage in patients with aneurysmal subarachnoid hemorrhage treated with anticoagulant thromboprophylaxis. Neurocrit Care. 2016;25(2):224–9.

    Article  CAS  Google Scholar 

  73. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–82.

    Article  Google Scholar 

  74. Karic T, Roe C, Nordenmark TH, Becker F, Sorteberg A. Impact of early mobilization and rehabilitation on global functional outcome one year after aneurysmal subarachnoid hemorrhage. J Rehabil Med. 2016;48(8):676–82.

    Article  Google Scholar 

  75. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.

    Article  Google Scholar 

  76. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G, et al. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112.

    Article  Google Scholar 

  77. Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Christopher E. Dukatz

  2. Department of Anesthesiology and Perioperative Medicine and Neurological Surgery, Oregon Health and Science University, Portland, OR, USA

    Ines P. Koerner

Authors
  1. Christopher E. Dukatz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ines P. Koerner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ines P. Koerner .

Editor information

Editors and Affiliations

  1. Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India

    Hemanshu Prabhakar

  2. Division of Neuroanesthesiology, Department of Anesthesiology, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India

    Zulfiqar Ali

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dukatz, C.E., Koerner, I.P. (2019). Critical Care Management of Subarachnoid Hemorrhage. In: Prabhakar, H., Ali, Z. (eds) Textbook of Neuroanesthesia and Neurocritical Care. Springer, Singapore. https://doi.org/10.1007/978-981-13-3390-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3390-3_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3389-7

  • Online ISBN: 978-981-13-3390-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation